Resistance to dasatinib is associated with the activation of Akt in oral squamous cell carcinoma-Reference-Cited by-同舟云学术

Resistance to dasatinib is associated with the activation of Akt in oral squamous cell carcinoma

Published:2017-01 Issue: Volume:2 Page:2057178X1770292
ISSN:2057-178X
Container-title:Translational Research in Oral Oncology
language:en
Short-container-title:Translational Research in Oral Oncology

Author:

Yee Pei San¹,Gan Chai Phei¹,Zainal Nur Syafinaz¹,Chiang Ivy KN¹²,Dionne Kalen R¹²³,Fadlullah Muhammad ZH¹,Lee Bernard KB¹,Tiong Kai Hung¹²,Mun Kein Seong⁴,Abraham Mannil T⁵,Ismail Siti M⁶,Rahman Zainal A Abdul⁶,Patel Vyomesh¹,Cheong Sok Ching¹⁶

Affiliation:

1. Oral Cancer Team, Cancer Research Malaysia, Selangor, Malaysia

2. Oral Cancer Research and Co-ordinating Centre (OCRCC), Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia

3. Medical Scientist Training Program, University of Colorado Denver, Aurora, CO, USA

4. Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

5. Department of Oral and Maxillofacial Surgery, Tengku Ampuan Rahimah Hospital, Klang, Malaysia

6. Department of Oral & Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia

Funder

Universiti Malaya

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/2057178X17702920

Reference51 articles.

1. Global cancer statistics, 2012

2. Advances in the systemic treatment of head and neck cancers

3. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

4. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of allosteric inhibitor against AKT1 through structure-based virtual screening;Molecular Diversity;2022-12-15